Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

Bridging the Gap in FDA Approval for Pediatric Neuromodulation Devices.

PMID: 40003250 ·

A, m, m, a, r, , S, h, a, i, k, h, o, u, n, i, ;, , C, a, m, e, r, o, n, , B, r, a, n, d, o, n, ;, , C, o, r, y, , C, r, i, s, s

RevistaChildren (Basel, Switzerland)
Año
PMID40003250

Resumen

While neuromodulation devices for managing neurological conditions have significantly advanced, there remains a substantial gap in FDA-approved devices specifically designed for pediatric patients. Devices like deep brain stimulators (DBS), vagus nerve stimulators (VNS), and spinal cord stimulators (SCS) are primarily approved for adults, with few options for children. To meet pediatric needs, off-label use is common; however, unique challenges to pediatric device development-such as ethical con

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑